Influence of clinical trial enrollment on the quality of care and outcomes for patients with non–ST-segment elevation acute coronary syndromes
David E. Kandzari(Piedmont Atlanta Hospital), Eric D. Peterson, Matthew T. Roe(Clinical Research Institute), Robert A. Harrington(Clinical Research Institute), Anita Y. Chen(University of Rochester Medicine), Barbara L. Lytle(Duke University), E. Magnus Ohman(Tarzana Treatment Centers), W. Brian Gibler(University of Cincinnati), Charles V. Pollack
Cited by 73
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k